Goldman hires ex-PEP dealmaker for Australia, New Zealand
Goldman Sachs has recruited David Grayce, formerly of Pacific Equity Partners, as part of efforts to expand its private investing business in Australia and New Zealand.
Based in Sydney, Grayce will serve as a managing director in the growth and corporate equity team with a brief to source and lead deals. He will report to Stephanie Hui, head of Asia private equity and...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.